Onderneming Voyager Therapeutics, Inc.
Aandelen
VYGR
US92915B1061
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,43 USD | +0,84% | +13,48% | -0,24% |
02/04 | Voyager Therapeutics, Inc. Benoemt Robin Swartz tot hoofd boekhouding | CI |
26/03 | VOYAGER THERAPEUTICS, INC. : Guggenheim handhaaft koopadvies | ZM |
Vakgebied
Aantal werknemers: 162
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Gene Therapies
100,0
%
| 41 | 100,0 % | 250 | 100,0 % | +511,16% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 41 | 100,0 % | 250 | 100,0 % | +511,16% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 01-03-22 |
Michael Higgins
CHM | Chairman | 61 | 22-07-15 |
Director of Finance/CFO | 55 | 19-09-22 | |
Todd Carter
CTO | Chief Tech/Sci/R&D Officer | 54 | 01-11-18 |
Robin Swartz
COO | Chief Operating Officer | 53 | 01-09-21 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 05-01-17 |
James Geraghty
BRD | Director/Board Member | 70 | 01-01-14 |
Beth Shafer
PRN | Corporate Officer/Principal | - | 07-08-23 |
Human Resources Officer | - | 14-09-20 | |
General Counsel | - | 10-07-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
George Scangos
BRD | Director/Board Member | 76 | 09-05-23 |
James Geraghty
BRD | Director/Board Member | 70 | 01-01-14 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 05-01-17 |
Catherine Mackey
BRD | Director/Board Member | 68 | 15-08-22 |
Steven E. Hyman
BRD | Director/Board Member | 71 | 17-09-15 |
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 01-03-22 |
Grace E. Colón
BRD | Director/Board Member | 57 | 01-01-23 |
Nancy J. Vitale
BRD | Director/Board Member | - | 15-09-20 |
Michael Higgins
CHM | Chairman | 61 | 22-07-15 |
Jude Onyia
BRD | Director/Board Member | 60 | 21-02-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 54 388 336 | 45 192 190 ( 83,09 %) | 0 | 83,09 % |
Bedrijfsgegevens
Voyager Therapeutics, Inc.
75 Hayden Avenue
02421, Lexington
+857 259 5340
http://www.voyagertherapeutics.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,24% | 455 mln. | |
+22,61% | 42,68 mld. | |
-3,27% | 42,4 mld. | |
+45,32% | 40,04 mld. | |
-6,20% | 28,31 mld. | |
+8,22% | 24,94 mld. | |
-19,93% | 18,96 mld. | |
+29,71% | 12,3 mld. | |
-3,11% | 11,95 mld. | |
-2,03% | 11,55 mld. |
- Beurs
- Aandelen
- Koers VYGR
- Onderneming Voyager Therapeutics, Inc.